DSCSA in Virginia.
In Virginia, the Board of Pharmacy licenses in-state wholesale distributors and registers nonresident ones, while the Drug Supply Chain Security Act's tracing rules apply as they do in every state.
In Virginia, no one may engage in wholesale distribution of prescription drugs without a licence from the Board of Pharmacy, under Code of Virginia section 54.1-3435. A distributor outside Virginia that ships into the Commonwealth registers with the Board as a nonresident wholesale distributor under section 54.1-3435.01. Both renew every year.
DSCSA in Virginia, in three facts.
US DSCSA · federal tracing rules · Virginia licensing · authorized trading partners.
No one may engage in wholesale distribution of prescription drugs in Virginia without a licence from the Board of Pharmacy, renewed every year, and a licensee notifies the Board within 30 days of any substantive change in its application information.
Source: Code of Virginia, sections 54.1-3435(A) and 54.1-3401 (Virginia General Assembly, Legislative Information System)A wholesale distributor located outside Virginia that distributes prescription drugs into the Commonwealth must register with the Board of Pharmacy as a nonresident wholesale distributor, renew every year and keep a valid licence, permit or registration in its home state.
Source: Code of Virginia, section 54.1-3435.01(A) and (B) (Virginia General Assembly, Legislative Information System)A nonresident wholesale distributor keeps records of prescription drugs distributed into Virginia readily retrievable and provides them to the Board of Pharmacy within seven days of a request.
Source: Code of Virginia, section 54.1-3435.01(C) (Virginia General Assembly, Legislative Information System)
Federal tracing, Virginia licensing.
In-state: a Board licence, renewed yearly
Section 54.1-3435 makes it unlawful to engage in wholesale distribution of prescription drugs in the Commonwealth without a valid licence issued by the Board of Pharmacy. The licence is renewed every year on a date set in the Board's regulations, and the Board must be told within 30 days of any substantive change in the information on the application.
Out-of-state: nonresident registration
Under section 54.1-3435.01, a firm located outside Virginia that distributes prescription drugs into the Commonwealth registers with the Board as a nonresident wholesale distributor, renews every year, pays the same fee as an in-state distributor and must hold a valid licence, permit or registration in the state where it is located, with proof at application and each renewal.
The tracing rules are federal
Product identifiers, electronic transaction data, verification and six-year records are the same in every state. DSCSA sets one national standard and a state may not add its own tracing rules on top.
Report the licence to FDA
Wholesale distributors and 3PLs report their state licences to FDA every year. Your trading partners can look you up in FDA's database, and you can look them up.
The timeline, as it stands.
The federal dates are the same in every state. The last exemption still running is for small dispensers, and it ends on 27 November 2027.
Three moves that de-risk the deadline.
Keep Virginia records apart and ready
Section 54.1-3435.01 requires a nonresident wholesale distributor to keep records of prescription drugs distributed into Virginia readily retrievable from its records for other jurisdictions, and to give them to the Board within seven days of a request. Section 54.1-3435 also requires a distributor that stops supplying Schedule II to V drugs to a Virginia pharmacy because of suspicious orders to tell the Board within five days.
Keep proof of every partner's licence
For each supplier and customer in Virginia, keep a dated copy of the licence check. Under DSCSA you may trade only with authorized trading partners, and an auditor will ask how you know.
Test a trace
Pick one unit shipped or received last quarter and produce its transaction data. Wholesale distributors have one business day to answer FDA, and dispensers have two.
One record, whichever state.
Aeroz ties each unit's physical identity to its transaction record, so a scan in Virginia produces the same evidence as a scan anywhere else: who held the unit, when, and whether it matched its data. The licence is yours to hold. We make the tracing side quick to prove.
DSCSA in Virginia, answered.
Who licenses drug wholesalers in Virginia?
The Virginia Board of Pharmacy, under Code of Virginia section 54.1-3435. The Board sits under the Department of Health Professions.
Does an out-of-state wholesale distributor need to register in Virginia?
Yes. Section 54.1-3435.01 requires any wholesale distributor located outside Virginia that distributes prescription drugs into the Commonwealth to register with the Board of Pharmacy as a nonresident wholesale distributor and renew every year.
Does a 3PL need a Virginia permit?
Virginia law refers to a third-party logistics provider permit and a nonresident third-party logistics provider registration, which the Board may deny, suspend or revoke under section 54.1-3435.1. Confirm the right one with the Board for your sites.
Does Virginia have its own drug tracing rules?
No. DSCSA tracing is federal and the same in every state. Section 54.1-3435.1 lets the Board act against licensees that break DSCSA's minimum requirements, but the tracing duties themselves come from federal law.
Does Virginia have its own track-and-trace rules?
No. DSCSA sets a single national standard for tracing prescription drugs, and a state may not set tracing requirements that differ from it. Virginia controls licensing; the tracing duties come from federal law.
How do I check that a Virginia trading partner is authorized?
Check its licence with the Virginia Board of Pharmacy, and look it up in FDA's wholesale distributor and 3PL reporting database. Under DSCSA you may trade only with partners that hold a valid licence or registration.
Know exactly where you stand, in 14 days.
A fixed-fee Aeroz audit maps your products against DSCSA requirements for trading partners in Virginia and returns a written readiness assessment, a data-mapping review, and a scoped pilot plan with cost and timeline.